SMMT FY 2021 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+110.3% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$86M-4764.3% margin

Net Income

-$89M-4897.8% margin

EPS (Diluted)

$-0.96

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$73M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$113M

Total Liabilities

$30M

Stockholders' Equity

$83M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$860,000	+110.3%
Gross Profit	$2M	$860,000	+110.3%
Operating Income	-$86M	-$53M	-62.0%
Net Income	-$89M	-$53M	-68.1%